Secondary placing of 1.7 million shares in Clavis Pharma ASA (NO) — NOK 84 million

Carnegie acted as sole manager in the secondary placing of 1.7 million shares in Clavis Pharma ASA, at a price of NOK 50.50 per share. The seller was MVM Life Science Partners LLP. Clavis Pharma ASA is an oncology focused pharmaceutical company.January, 2010.